SAN DIEGO, Feb. 24, 2022 /PRNewswire/ -- Cue Health
("Cue") (Nasdaq: HLTH), the healthcare technology company behind
the country's most accurate at-home COVID-19 test*, is
partnering with three-time NBA All-Star Karl-Anthony Towns to donate $250,000 of Cue Readers and COVID-19 tests to
public schools in Towns' home state of New Jersey and Minneapolis, Karl-Anthony's home throughout
his entire playing career. Towns' alma mater, Saint Joseph High
School in Metuchen, NJ, will be
the program's first recipient with 100 Cue tests to be delivered
this month, followed by delivery to the Piscataway Township Schools in New Jersey.
![(PRNewsfoto/Cue Health Inc.) (PRNewsfoto/Cue Health Inc.)](https://mma.prnewswire.com/media/1422556/Cue_Logo.jpg)
Regular COVID-19 testing is a cause that hits close to home for
Towns, who lost multiple family members, including his mother, to
the virus before also battling it himself. Cue's molecular
self-test can detect COVID-19 with few virus present, versus
antigen tests that require notably more virus in the sample. This
level of accuracy is vital for parents and teachers working to keep
their kids safely in school, as people can still be infectious with
well below the amount of virus it takes to trigger a rapid antigen
positive result.
Through this partnership, Towns and Cue have committed to
donating 100 COVID-19 tests to each of a select 50 schools in
New Jersey and Minnesota, ensuring that accurate testing is
available at the schools right when they need it most. After
kicking off with Saint Joseph's
High School, additional schools will receive donations of Cue
throughout the remainder of the school year.
"My family was devastated by COVID-19, and highly accurate
testing that we can rely on at home and on-the-go has been key as
we work to recover and move forward," commented Karl-Anthony Towns, the Minnesota Timberwolves
center. "I learned about Cue when the NBA started working with the
company in 2020 and it really put my mind at ease to know we were
using the most accurate tests. Through this donation, I'm hoping to
bring peace of mind to the students and teachers in my communities,
helping them get back to learning safely and confidently."
"Karl-Anthony has been a great supporter of ours from the very
beginning of our work with the NBA," added Ayub Khattak, CEO and co-founder of Cue Health.
"I admire his resilience and drive to get back out on the court
safely. At Cue, we know that access to accurate testing is key for
people to confidently live their lives, and I'm honored that he is
working alongside us to help bring Cue to more people."
Cue's COVID-19 test is available at shop.cuehealth.com and can
be purchased a la carte or through its membership model. In
addition to the most accurate at-home COVID-19 testing available,
Cue+ memberships include benefits such as access to 24/7 virtual
care, prescription services, same-day delivery in select markets
and supervised testing by virtual proctor, which is CDC-compliant
for international travel.
Prior to its donation effort in partnership with Karl-Anthony Towns, Cue has played an active
role in bringing accurate testing to schools across the country
with the Cue For Schools program. To date, Cue has been distributed
to 2,000 schools across 20 states.
*Based on clinical study results submitted to FDA for other
EUA molecular home tests.
About Cue Health
Cue Health (Nasdaq: HLTH) is a
healthcare technology company that makes it easy for individuals to
access health information and places diagnostic information at the
center of care. Cue Health enables people to manage their health
through real-time, actionable, and connected health information,
offering individuals and their healthcare providers easy access to
lab-quality diagnostics anywhere, anytime, in a device that fits in
the palm of the hand. Cue Health's first-of-its-kind COVID-19 test
was the first FDA-authorized molecular diagnostic test for at-home
and over-the-counter use without a prescription and physician
supervision. Outside the United
States, Cue Health has received the CE mark in the European
Union, Interim Order authorization from Health Canada, regulatory
approval from India's Central
Drugs Standard Control Organization, and PSAR authorization from
Singapore's Health Sciences
Authority. Cue was founded in 2010 and is headquartered in
San Diego. For more information,
please visit www.cuehealth.com.
The Cue COVID-19 Test for Home and Over The Counter (OTC) Use
has not been FDA cleared or approved; but has been authorized by
FDA under an Emergency Use Authorization (EUA). This product has
been authorized only for the detection of nucleic acid from
SARS-CoV-2, not for any other viruses or pathogens. The emergency
use of this product is only authorized for the duration of the
declaration that circumstances exist justifying the authorization
of emergency use of in vitro diagnostics for detection and/or
diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food,
Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the
declaration is terminated or authorization is revoked
sooner.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cue-health-and-karl-anthony-towns-team-up-to-donate-250k-of-cues-covid-19-tests-to-schools-in-new-jersey-and-minnesota-301489205.html
SOURCE Cue Health Inc.